Arcus Biosciences (RCUS) Enterprise Value (2018 - 2026)
Arcus Biosciences' Enterprise Value was $3.21 billion in Q2 2026, compared with -$44.9 million a year earlier and up 70.1% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Enterprise Value (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arcus Biosciences' Enterprise Value was $579.41 million through Jun 30, 2026; for FY2025, it was $2 billion, up 407.8% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of 15.8% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $394.86 million in FY2024 (-42.2%), $683.05 million in FY2023 (+37.0%), $498.57 million in FY2022 (-78.9%) and $2.37 billion in FY2021 (+146.0%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value in data going back to Q1 2018.
- Compared with a year earlier, Enterprise Value was higher in two of the last four quarters, with growth averaging 106.1%.
- The best year-over-year quarter for Enterprise Value over five years was Q3 2021 (growth of 482.6%); the worst was Q4 2022 (a decline of 78.9%).
- Per Business Quant data, RCUS's Enterprise Value in the three quarters before Q2 2026 was $1.89 billion (Q1 2026), $2 billion (Q4 2025) and $625.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Arcus Biosciences | 3.18 Bn | -157.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.21 Bn |
| Mar 31, 2026 | 1.89 Bn |
| Dec 31, 2025 | 2.00 Bn |
| Sep 30, 2025 | 625.56 Mn |
| Jun 30, 2025 | -44.90 Mn |
| Mar 31, 2025 | -165.69 Mn |
| Dec 31, 2024 | 394.86 Mn |
| Sep 30, 2024 | 310.03 Mn |
| Jun 30, 2024 | 421.50 Mn |
| Mar 31, 2024 | 721.19 Mn |
| Dec 31, 2023 | 683.05 Mn |
| Sep 30, 2023 | 543.66 Mn |
| Jun 30, 2023 | 583.09 Mn |
| Mar 31, 2023 | 379.34 Mn |
| Dec 31, 2022 | 498.57 Mn |
| Sep 30, 2022 | 843.60 Mn |
| Jun 30, 2022 | 653.50 Mn |
| Mar 31, 2022 | 1.05 Bn |
| Dec 31, 2021 | 2.37 Bn |
| Sep 30, 2021 | 1.92 Bn |
API Access
Arcus Biosciences Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();